Intercept to Present at the Bank of America Merrill Lynch Virtual Global Healthcare Conference

Rhea-AI Summary

Intercept Pharmaceuticals (Nasdaq: ICPT) has announced that its President and CEO, Mark Pruzanski, will present at the Bank of America Merrill Lynch Virtual Global Healthcare Conference on May 13, 2020, at 2:20 p.m. ET. Investors can access a live webcast on the company’s investor page, with an audio archive available for two weeks post-event. Intercept focuses on developing therapeutics for progressive non-viral liver diseases, including primary biliary cholangitis and nonalcoholic steatohepatitis.

NEW YORK, May 06, 2020 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that Mark Pruzanski, M.D., President and Chief Executive Officer of Intercept, will present at the Bank of America Merrill Lynch Virtual Global Healthcare Conference on Wednesday, May 13, 2020 at 2:20 p.m. ET.

A live webcast of the event will be available on the investor page of Intercept’s website at http://ir.interceptpharma.com. An audio archive of the webcast will also be available on Intercept’s website for approximately two weeks.

About Intercept
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada. For more information, please visit www.interceptpharma.com or connect with the company on Twitter and LinkedIn.

CONTACT

For more information about Intercept, please contact:

Investor inquiries: investors@interceptpharma.com

Media inquiries: media@interceptpharma.com

Source: Intercept Pharmaceuticals, Inc.

FAQ

What event will Intercept Pharmaceuticals' CEO present at?

Mark Pruzanski, CEO of Intercept Pharmaceuticals, will present at the Bank of America Merrill Lynch Virtual Global Healthcare Conference on May 13, 2020.

When is the presentation by Mark Pruzanski?

Mark Pruzanski's presentation is scheduled for May 13, 2020, at 2:20 p.m. ET.

Where can I watch the Intercept Pharmaceuticals presentation?

The presentation can be watched live on Intercept Pharmaceuticals' investor page.

What diseases does Intercept Pharmaceuticals focus on?

Intercept Pharmaceuticals focuses on developing treatments for progressive non-viral liver diseases, including primary biliary cholangitis and nonalcoholic steatohepatitis.

How long will the audio archive of the presentation be available?

The audio archive of the webcast will be available on Intercept's website for approximately two weeks.